Unknown

Dataset Information

COVID-19 mRNA vaccine allergy.


ABSTRACT:

Purpose of review

A known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine is the only contraindication to coronavirus disease 2019 (COVID-19) mRNA vaccination. It is important for pediatricians to understand the likelihood of an allergic reaction to COVID-19 mRNA vaccines, including its excipients.

Recent findings

Episodes concerning for anaphylaxis were immediately reported following early administration of COVID-19 mRNA vaccines to adults. Although allergic type symptoms were reported equally in recipients of placebos and test vaccines in phase 3 clinical trials, post-authorization prospective studies state that 0.2-2% of vaccine recipients have experienced allergic reactions. Subsequent allergy testing of affected individuals has

SUBMITTER: Risma KA 

PROVIDER: S-EPMC8577302 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature